Dose response of subcutaneous GLP-1 infusion in patients with type 2 diabetes.
about
Treatment with a GLP-1 receptor agonist diminishes the decrease in free plasma leptin during maintenance of weight loss.Efficacy and safety of liraglutide versus placebo added to basal insulin analogues (with or without metformin) in patients with type 2 diabetes: a randomized, placebo-controlled trial.Combining GLP-1 receptor agonists with insulin: therapeutic rationales and clinical findings.Therapies for inter-relating diabetes and obesity - GLP-1 and obesity.Liraglutide for Type 2 diabetes and obesity: a 2015 update.The effect of a subcutaneous infusion of GLP-1, OXM and PYY on Energy intake and Expenditure in Obese volunteers.Pharmacokinetic/pharmacodynamic modeling of GLP-1 in healthy rats.Cooperative role of the glucagon-like peptide-1 receptor and β3-adrenergic-mediated signalling on fat mass reduction through the downregulation of PKA/AKT/AMPK signalling in the adipose tissue and muscle of rats.Dose response of continuous subcutaneous infusion of recombinant glucagon-like peptide-1 in combination with metformin and sulphonylurea over 12 weeks in patients with type 2 diabetes mellitus.Weight loss and weight maintenance obtained with or without GLP-1 analogue treatment decrease branched chain amino acid levelsGlucagon-like peptide-1 does not have acute effects on central or renal hemodynamics in patients with type 2 diabetes without nephropathy
P2860
Q34665186-50F2FD52-F3E1-49D9-8281-DCAC7A23E8A3Q37320537-D2F92842-F438-49E1-BC61-AEB98A2C0A99Q38014516-BAA63947-1114-4903-9702-EABA3DC04A18Q38254745-2993A489-E722-475D-9D26-15C8F04DD9C4Q38536672-394888CA-7A32-4E66-ABDC-01FA7523D42DQ38853094-516944C9-5B3E-477B-8BAB-AA50FCC22945Q41845173-7164755E-1DB8-4CB3-8A03-14A1A48A7C1CQ47343137-9CA59D2D-A45F-4745-81FA-DBC7605BFC1CQ51331106-D2983EAE-DDE0-49F1-A7BA-979A46D695F6Q57655866-F1DC360F-A1D4-4058-A139-305CACB41B1FQ58167256-FA667C43-1C0D-4722-8F0B-C25744649258
P2860
Dose response of subcutaneous GLP-1 infusion in patients with type 2 diabetes.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
Dose response of subcutaneous GLP-1 infusion in patients with type 2 diabetes.
@en
Dose response of subcutaneous GLP-1 infusion in patients with type 2 diabetes.
@nl
type
label
Dose response of subcutaneous GLP-1 infusion in patients with type 2 diabetes.
@en
Dose response of subcutaneous GLP-1 infusion in patients with type 2 diabetes.
@nl
prefLabel
Dose response of subcutaneous GLP-1 infusion in patients with type 2 diabetes.
@en
Dose response of subcutaneous GLP-1 infusion in patients with type 2 diabetes.
@nl
P2093
P2860
P1476
Dose response of subcutaneous GLP-1 infusion in patients with type 2 diabetes.
@en
P2093
M R Ehlers
M S Kipnes
R E Harley
P2860
P304
P356
10.1111/J.1463-1326.2011.01388.X
P577
2011-07-01T00:00:00Z